Symphogen
Ivan Horak has extensive experience in the pharmaceutical and biotech industry. Ivan currently serves as the President of Research and Development at Tessa Therapeutics Ltd. Prior to this role, they worked as the Chief Scientific and Medical Officer at Symphogen. Ivan also held the position of CSO and CMO at The Global Leaders. Ivan Horak was the Chief Scientific Officer and President of Research and Development at Eznon from 2010 to 2011. Ivan served as the CSO and president of R&D at Enzon Pharmaceuticals from 2005 to 2011. Ivan also worked as the CSO at Immunomedics from 2002 to 2005. Ivan Horak started their career at Pharmacia as the VP of Clinical Oncology from 1999 to 2002.
Ivan Horak obtained a medical degree specializing in medicine from Kommenius Medical School, where they studied from 1969 to 1975.
This person is not in any offices